Can an mRNA injection slow aging? new study begins
Disease control
Not yet recruiting
This early-stage study tests a new mRNA treatment called AKL003 in healthy adults aged 50 to 90. The goal is to see if it is safe and can increase levels of a protein linked to aging. Participants will receive two injections and be monitored for side effects and protein levels.
Phase: PHASE1 • Sponsor: Klothea Bio Inc • Aim: Disease control
Last updated May 07, 2026 18:41 UTC